Oxford University to test COVID-19 vaccine response among children for first time

AFP

The University of Oxford has launched a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc in children for the first time, it said on Saturday.

The new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17, according to an emailed statement from the university.

Around 300 volunteers will be enrolled and first inoculations are expected this month, Oxford said.

The two-dose Oxford/AstraZeneca vaccine has been hailed as a "vaccine for the world" because it is cheaper and easier to distribute than some rivals.

AstraZeneca has a target to produce 3 billion doses this year and aims to produce over 200 million doses per month by April. 

More from International

Coming Up on Dubai Eye

  • Afternoons with Helen Farmer

    2:00pm - 5:00pm

    Every weekday afternoon, Helen Farmer will help you to navigate the highs and lows of life in the UAE. Stay up to date with what’s happening and where to go.

  • Off Script with Chris, Robbie & Sonal

    5:00pm - 7:00pm

    The UAE’s alternative take on news, entertainment and sport. Join Chris, Robbie and Sonal as they cut through the clutter to bring you the news, entertainment and sport stories that actually matter.

BUSINESS BREAKFAST LATEST

On Dubai Eye

  • Honouring Kian's life

    Goli lost her five-year-old son Kian in a tragic accident on Boxing Day. Today, we honour Kian's memory and send our love to Goli and her family.

  • Combatting COVID-19: Dubai amends travel protocols

    Dubai’s Supreme Committee of Crisis & Disaster Management has announced amendments to travel protocols as part of preventive measures to limit the spread of COVID-19.